July 9, 2020 / 7:01 AM / a month ago

BRIEF-UK's CMA Says Aspen, Tiofarma, Amilco Admit Taking Part In Anti-Competitive Agreement

July 9 (Reuters) - Aspen Pharmacare Holdings Ltd:

* CMA LEVIES FINES OF £2.3M AND SECURES £8M FOR NHS IN PHARMA PROBE

* UK’S CMA - FORMALLY CONCLUDED THAT 3 PHARMACEUTICAL COMPANIES TOOK PART IN AN ILLEGAL ARRANGEMENT IN RELATION TO SUPPLY OF LIFE-SAVING MEDICINE

* CMA - FOUND PHARMA COMPANIES AMILCO, TIOFARMA AGREED TO STAY OUT OF FLUDROCORTISONE MARKET SO ASPEN COULD MAINTAIN ITS POSITION AS SOLE SUPPLIER IN UK

* UK’S CMA - AS WELL AS FINES, ASPEN APPROACHED CMA LAST YEAR, AGREED TO PAY NHS £8 MILLION TO HELP RESOLVE COMPETITION CONCERNS ON FLUDROCORTISONE

* CMA - ASPEN, TIOFARMA, AND AMILCO ADMITTED TO TAKING PART IN AN ANTI-COMPETITIVE AGREEMENT REGARDING SUPPLY OF FLUDROCORTISONE TABLETS. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below